These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 33408716)

  • 21. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer nanomedicine meets immunotherapy: opportunities and challenges.
    Sun Q; Bai X; Sofias AM; van der Meel R; Ruiz-Hernandez E; Storm G; Hennink WE; De Geest B; Kiessling F; Yu HJ; Lammers T; Shi Y
    Acta Pharmacol Sin; 2020 Jul; 41(7):954-958. PubMed ID: 32555445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicine-based tumor photothermal therapy synergized immunotherapy.
    Shang T; Yu X; Han S; Yang B
    Biomater Sci; 2020 Oct; 8(19):5241-5259. PubMed ID: 32996922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
    Martin JD; Cabral H; Stylianopoulos T; Jain RK
    Nat Rev Clin Oncol; 2020 Apr; 17(4):251-266. PubMed ID: 32034288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-viral gene delivery for cancer immunotherapy.
    Wang W; Saeed M; Zhou Y; Yang L; Wang D; Yu H
    J Gene Med; 2019 Jul; 21(7):e3092. PubMed ID: 30991453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Targeted Nanocarriers for Immunotherapy.
    Baeza A
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32225049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
    Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
    Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy.
    Li J; Luo Y; Pu K
    Angew Chem Int Ed Engl; 2021 Jun; 60(23):12682-12705. PubMed ID: 32671893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic Near-Infrared-II Nanophotosensitizer for Safe Cancer Phototheranostics and Improving Immune Microenvironment against Metastatic Tumor.
    Song C; Ran J; Wei Z; Wang Y; Chen S; Lin L; Zhang G; Cai Y; Han W
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3547-3558. PubMed ID: 33443401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering safer immunotherapies for cancer.
    Milling L; Zhang Y; Irvine DJ
    Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging-assisted anticancer nanotherapy.
    Dasgupta A; Biancacci I; Kiessling F; Lammers T
    Theranostics; 2020; 10(3):956-967. PubMed ID: 31938045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.
    La-Beck NM; Islam MR; Markiewski MM
    Front Immunol; 2020; 11():603039. PubMed ID: 33488603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
    Zhong XF; Sun X
    Acta Pharmacol Sin; 2020 Jul; 41(7):928-935. PubMed ID: 32355277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.
    Yang Y; Zhao T; Chen Q; Li Y; Xiao Z; Xiang Y; Wang B; Qiu Y; Tu S; Jiang Y; Nan Y; Huang Q; Ai K
    Adv Sci (Weinh); 2022 Oct; 9(28):e2202797. PubMed ID: 35869032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional nanomedicines for synergistic photodynamic immunotherapy based on tumor immune microenvironment.
    Guo R; Liu Y; Xu N; Ling G; Zhang P
    Eur J Pharm Biopharm; 2022 Apr; 173():103-120. PubMed ID: 35283303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
    Inthagard J; Edwards J; Roseweir AK
    Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smart cancer nanomedicine.
    van der Meel R; Sulheim E; Shi Y; Kiessling F; Mulder WJM; Lammers T
    Nat Nanotechnol; 2019 Nov; 14(11):1007-1017. PubMed ID: 31695150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-based nanosystems: the next generation of cancer immune therapy.
    Cheng Z; Fobian SF; Gurrieri E; Amin M; D'Agostino VG; Falahati M; Zalba S; Debets R; Garrido MJ; Saeed M; Seynhaeve ALB; Balcioglu HE; Ten Hagen TLM
    J Hematol Oncol; 2024 Jul; 17(1):53. PubMed ID: 39030582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.